The Nashville Business Journal is talking about change:healthcare and the Keystone Institute’s new partnership.
“The Keystone Institute for Translational Medicine — an alliance of three Pennsylvania medical institutions led by Temple University — is researching the genetic, behavioral and social causes of diseases such as diabetes, hypertension, lung disease, obesity and certain cancers that affect urban [...]
Read the full article →
change:healthcare has been chosen by GeneSyn IP Ventures, LLC, a partner of the Keystone Institute for Translational Medicine in Philadelphia, Penn., to support a national translational medicine technology consortium, officials announced today.
The move is intended to help the Keystone Institute for Translational Medicine more quickly reach their goal of increasing the speed with which medical [...]
Read the full article →